Dr. Rabab Ahmed Mohammed
Associate Professor of Pathology
|
rababam@agu.edu.bh
|
|
| Curriculum Vitae | Download |
| Google Scholar |
Go To Page
|
Dr. Rabab Mohammed has started her specialty in Histopathology [Clinical diagnosis, teaching and research projects] since 2000. She earned the MBChB degree from Assiut University in 1997, then MSc degree in histopathology from the same university in 2002. She completed her PhD degree in diagnostic Molecular Pathology from University of Nottingham (UK) and fellowship at QMC, Nottingham, UK in 2010. Certified as a consultant of surgical pathology by the Saudi Commission for Health Specialties and the Egyptian Syndicate. The main interest and expertise are translational research in breast cancer. Recent research project in cancer immunology in breast cancer is underway. She has more than 60 published articles in highest ranked pathology journals in addition to abstract submissions to national and international conferences and meetings. She is a member and a winner of several international awards from the USCAP, Pathological Society of Great Britain and Ireland and the EACR.
- Ph.D. in Pathology/Diagnostic molecular Pathology, University of Nottingham, UK, 2010
- M.Sc in Pathology, Assiut University, Egypt, 2002
- MBBCH, A Bachelor of Medicine and Surgery University, Assiut University, Egypt, 1997
- Cancer immunology in breast cancer and ovarian cancer
- Histopathological features and molecular mechanisms controlling vascular invasion and progression in breast cancer
- Undergraduate teaching for medical students
- Postgraduate teaching for junior pathology staff members
- Training of registrars in Histopathology
- Aberration of Nrf2Bach1 pathway in colorectal carcinoma; role in carcinogenesis and tumor progression. Annual of Diagnostic Pathology, 2019.
- Prognostic significance of lymphatic invasion in lymph node-positive breast carcinoma: findings from a large case series with long-term follow-up using immunohistochemical endothelial marker. Modern Pathology, 2014.
- "Pattern of HER-2 gene amplification and protein expression in benign, borderline and malignant ovarian serous and mucinous neoplasms. International Journal of Gynecological Pathology, 2017.
- Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up, J Path, 2010.
- Interleukin-17 expression by breast cancer associated macrophages: IL-17 promotes MMP-dependent invasiveness of breast cancer cell lines. Breast Cancer Research, 2008